ANGO Financial Facts

Cost of sales: 43.4M
Interest expense: -998K
See Full Income Statement

DEFERRED INCOME TAXES, long term: 19.83M
INTANGIBLE ASSETS, less accumulated amortization: 172.51M
See Full Balance Sheet

AngioDynamics (ANGO) Earnings

  |   Expand Research on ANGO
Next EPS Date 4/8/16 *Est. EPS Growth Rate -17.6% *Last Qtr.
Average EPS % Beat Rate -6.3% Revenue Growth Rate -3.1% *Last Qtr.
Average % Move 1-Wk after EPS -4.5% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
1/7/16 Q216 $0.14$0.14 $0.00$89.2M$88.67M = Details
10/8/15 Q116 $0.11$0.11 $0.00$83.7M$84.7M = Details
7/16/15 Q415 $0.14$0.14 $0.00$90.9M$91.67M = Details
4/9/15 Q315 $0.12$0.16 -$0.04$86.6M$89.8M Details
1/8/15 Q215 $0.17$0.15 +$0.02$92.1M$90.9M Details
10/9/14 Q115 $0.16$0.11 +$0.05$87.3M$85.3M = Details
7/23/14 Q414 $0.18$0.12 +$0.06$94.1M$93.65M Details
4/9/14 Q314 $0.16$0.09 +$0.07$88.2M$86.85M N/A Details